The Europe animal health market was valued at USD 16.56 billion in 2024 and is projected to reach USD 34.84 billion by 2033, growing at a CAGR of 8.64% from 2025 to 2033. The market’s growth is primarily driven by the rising prevalence of zoonotic and infectious diseases, increasing pet ownership and humanization of companion animals, advancements in veterinary pharmaceuticals and biologics, and supportive government regulations and food safety standards. The frequent outbreaks of diseases such as bluetongue virus (BTV) and epizootic hemorrhagic disease (EHD) across Europe have intensified the demand for advanced vaccines, diagnostic tools, and preventive solutions to maintain herd health and biosecurity. As a result, both governments and private companies are increasing investments in veterinary R&D, disease surveillance systems, and innovative animal health programs to mitigate disease risks and strengthen livestock productivity.

The growing pet population and the cultural shift toward pet humanization have also become major contributors to the region’s market expansion. Pet owners are increasingly willing to spend more on premium-quality food, preventive healthcare, and wellness products to ensure their pets’ well-being. As per Animal Health Europe, European consumers spend approximately 28 billion euros on pet food, 25 billion on pet-related services, and 4 billion on animal medicines, underscoring the growing commitment to companion animal health. The increasing availability of pet insurance in countries like the UK, Sweden, and Germany further promotes access to high-quality veterinary care. Consequently, the companion animal segment has become one of the most dynamic and fastest-growing areas within the broader market, supported by the adoption of diagnostic testing, parasiticides, and veterinary medications.

Key Market Trends & Insights:

  • Based on product, the pharmaceuticals segment held the largest revenue share of 43.89% in 2024, supported by strong demand for efficient and safe treatments for both livestock and pets. Meanwhile, the “other” segment comprising veterinary telehealth services, software, and livestock monitoring technologies is expected to witness the highest growth rate through 2033, driven by the adoption of digital and precision health tools.
  • By animal type, the production animals segment accounted for the largest market share in 2024, emphasizing livestock’s critical role in Europe’s food supply chain and economic stability. However, the companion animal segment is anticipated to grow the fastest during the forecast period, fueled by rising pet ownership and increased veterinary care investments.

Order a free sample PDF of the Europe Animal Health Market Intelligence Study, published by Grand View Research.

Key Players

  • Ceva
  • Vetoquinol S.A.
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Braun Vet Care
  • Dechra Pharmaceuticals PLC
  • Bimed Inc.
  • Zoetic Inc.
  • Elanco
  • IDEXX Laboratories, Inc.
  • MSD Animal Health

Recent Developments

  • In June 2025, dsm-firmenichintroduced GutServ Biotix, a postbiotic solution aimed at boosting piglet gut integrity, reducing weaning stress, and promoting stronger early growth and resilience in commercial swine operations.
  • In June 2025, The University of León’s spin-off Aquilón Cyl developed Biobhyo approved by European Medicines Agency is the world’s first swine dysentery vaccine, showing 90% efficacy and EMA support, addressing antibiotic resistance and farm productivity.
  • In March 2025, altona Diagnosticslaunched the FlexStar FLU H5N1 Detection Mix 1.5 RUO, enabling qualitative real-time PCR detection of influenza A (H5N1) virus RNA for research applications.
  • In March 2025, Nawu Diagnostics launched a portable diagnostic device capable of detecting livestock respiratory pathogens in just 30 minutes, supporting faster treatment decisions and early intervention in farm settings.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

In conclusion, the Europe animal health market is poised for robust growth over the coming decade, supported by rising investments in disease prevention, diagnostic innovations, and advanced pharmaceuticals. The increasing burden of zoonotic diseases and the growing emphasis on animal welfare are driving stronger collaborations between governments, research institutions, and private players. Additionally, the expanding companion animal segment reflects changing social dynamics and the region’s growing preference for premium veterinary care. The integration of digital technologies, such as telehealth and portable diagnostics, is expected to further modernize veterinary practices. Overall, Europe’s animal health industry is evolving into a highly dynamic and innovation-driven sector focused on sustainability, productivity, and animal well-being.